NDC 55289-920-98
This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
- Product NDC
- 55289-920
- Requested NDC
- 55289-920-98
- Package NDCs from labels
- 55289-920-98
- Manufacturer
- National Council for Prescription Drug Programs
- Effective date
- 2012-07-24
- Current FDA listing
- Not matched in FDA.report NDC product tables
DailyMed Labels#
| Label | Manufacturer | Effective date | Type |
|---|---|---|---|
| National Council for Prescription Drug Programs indexing - billing unit | National Council for Prescription Drug Programs | 2012-07-24 | Indexing - Billing Unit |
DailyMed Billing Units#
| Package NDC | Billing unit | Product NDC | DailyMed indexing SPL | SPL version | Effective |
|---|---|---|---|---|---|
| 55289-920-06 | EA - Each | 55289-920 | 706d0221-1af2-41d4-9df2-bf37b14b690f | 1 | 2012-07-24 |
| 55289-920-30 | EA - Each | 55289-920 | 29427292-7c0b-4173-859f-ff32c417f2e7 | 1 | 2012-07-24 |
| 55289-920-40 | EA - Each | 55289-920 | 27fb6d9e-1de6-4d20-a60e-6518e959ca62 | 1 | 2012-07-24 |
| 55289-920-60 | EA - Each | 55289-920 | d88ef8cb-70eb-456a-8133-6265354cbc4a | 1 | 2012-07-24 |
| 55289-920-90 | EA - Each | 55289-920 | cd4fb9c8-ca98-40b2-8d76-5faca8c9fb4e | 1 | 2012-07-24 |
| 55289-920-98 | EA - Each | 55289-920 | 2a336a9c-9f8d-4b3f-8c19-cc8e37318b9d | 1 | 2012-07-24 |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Alprazolam | ALPRAZOLAM | Aurobindo Pharma Limited | 326fa31a-5420-429b-9f7f-170cb38f64bd | 2025-12-11 | Boxed warning, Warnings, Adverse reactions | Alprazolam ALPRAZOLAM |
| DEXAMETHASONE | DEXAMETHASONE | PD-Rx Pharmaceuticals, Inc. | a8d6792e-757e-4dc6-adf5-0d9211075428 | 2025-12-09 | Warnings, Adverse reactions | PD-Rx Pharmaceuticals, Inc. |
| cetirizine hydrochloride | CETIRIZINE HYDROCHLORIDE | PD-Rx Pharmaceuticals, Inc. | 03c0a599-072a-10ef-e063-6394a90a9698 | 2025-11-20 | Warnings | PD-Rx Pharmaceuticals, Inc. |
| Hydrochlorothiazide | HYDROCHLOROTHIAZIDE | PD-Rx Pharmaceuticals, Inc. | c182b6a9-1a31-45ee-9cea-a557c99f5db7 | 2025-11-20 | Warnings, Adverse reactions | PD-Rx Pharmaceuticals, Inc. |
| Amoxicillin and Clavulanate Potassium | AMOXICILLIN AND CLAVULANATE POTASSIUM | PD-Rx Pharmaceuticals, Inc. | b509d0eb-fe01-4902-89ae-a0dc7f7c7f93 | 2025-11-20 | Warnings, Adverse reactions | PD-Rx Pharmaceuticals, Inc. |
| Topiramate | TOPIRAMATE | PD-Rx Pharmaceuticals, Inc. | 1f327383-beb3-4d15-add6-5f1c749f2b3f | 2025-11-18 | Warnings, Adverse reactions | PD-Rx Pharmaceuticals, Inc. |
| POTASSIUM CHLORIDE | POTASSIUM CHLORIDE | PD-Rx Pharmaceuticals, Inc. | 018fc687-1fba-202e-e063-6294a90a5c9a | 2025-11-17 | Warnings, Adverse reactions | PD-Rx Pharmaceuticals, Inc. |
| Diphenhydramine HCL | DIPHENHYDRAMINE HCL | PD-Rx Pharmaceuticals, Inc. | c1873a4c-661f-4896-bcc0-f6d3a655de94 | 2025-11-13 | Warnings | PD-Rx Pharmaceuticals, Inc. |
| Doxepin Hydrochloride | DOXEPIN HYDROCHLORIDE | PD-Rx Pharmaceuticals, Inc. | 8f7e9677-cc84-414b-8eb8-33993d285bb3 | 2025-11-12 | Boxed warning, Warnings, Adverse reactions | PD-Rx Pharmaceuticals, Inc. |
| Cephalexin | CEPHALEXIN | PD-Rx Pharmaceuticals, Inc. | 6ce11859-aa21-4b3f-bd59-3cd26deca82b | 2025-11-07 | Warnings, Adverse reactions | PD-Rx Pharmaceuticals, Inc. |
| Ciprofloxacin | CIPROFLOXACIN | PD-Rx Pharmaceuticals, Inc. | 74e2dd24-5c6e-4dde-a2ab-f2d2e61734d8 | 2025-11-06 | Boxed warning, Warnings, Adverse reactions | PD-Rx Pharmaceuticals, Inc. |
| Ciprofloxacin | CIPROFLOXACIN HYDROCHLORIDE | PD-Rx Pharmaceuticals, Inc. | cfda82e4-8660-447e-a881-b87165a31e9a | 2025-11-06 | Boxed warning, Warnings, Adverse reactions | PD-Rx Pharmaceuticals, Inc. |
| hydroxyzine pamoate | HYDROXYZINE PAMOATE | PD-Rx Pharmaceuticals, Inc. | 53153595-41b9-4b2d-8b7d-0ffd29fdd1d8 | 2025-11-05 | Warnings, Adverse reactions | PD-Rx Pharmaceuticals, Inc. |
| Metformin HCl | METFORMIN HCL | PD-Rx Pharmaceuticals, Inc. | 235680e6-1c3e-45b8-902e-866583f1aef3 | 2025-11-04 | Warnings, Adverse reactions | PD-Rx Pharmaceuticals, Inc. |
| SULINDAC | SULINDAC | PD-Rx Pharmaceuticals, Inc. | eb7acb87-6565-4524-a91a-02064ea8bd1a | 2025-10-23 | Boxed warning, Warnings, Adverse reactions | PD-Rx Pharmaceuticals, Inc. |
| Carisoprodol Tablets, USP, 350 mg | CARISOPRODOL | PD-Rx Pharmaceuticals, Inc. | 1f08f4af-37c2-49b5-a4e3-284414f866fa | 2025-10-23 | Warnings, Adverse reactions | PD-Rx Pharmaceuticals, Inc. |
| Famotidine | FAMOTIDINE | PD-Rx Pharmaceuticals, Inc. | 002875d2-8c30-2d2e-e063-6294a90ae01e | 2025-10-22 | Warnings, Adverse reactions | PD-Rx Pharmaceuticals, Inc. |
| Prazosin Hydrochloride | PRAZOSIN HYDROCHLORIDE | PD-Rx Pharmaceuticals, Inc. | e5e129aa-2ee3-4c12-a327-5d5382cf2310 | 2025-10-21 | Warnings, Adverse reactions | PD-Rx Pharmaceuticals, Inc. |
| Prazosin Hydrochloride | PRAZOSIN HYDROCHLORIDE | PD-Rx Pharmaceuticals, Inc. | 5d7dff44-84b1-4044-bc5a-c76ea11dd5a3 | 2025-10-21 | Warnings, Adverse reactions | PD-Rx Pharmaceuticals, Inc. |
| Prazosin Hydrochloride | PRAZOSIN HYDROCHLORIDE | PD-Rx Pharmaceuticals, Inc. | cd52f022-ca29-4f87-8684-da63e05b3c1f | 2025-10-21 | Warnings, Adverse reactions | PD-Rx Pharmaceuticals, Inc. |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.